Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL

Clinical trial NCT00311129 · COMPLETED

Trial details

NCT number: NCT00311129
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Low-Grade

Start date: 2005-12-01
Primary completion: 2007-07-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.